Skip to main content

Market Overview

Citigroup Upgrades AMKR and TER To Buy


Citigroup has published a research report on Amkor Technology (NASDAQ: AMKR) and Teradyne, Inc. (NYSE: TER) and has upgraded both companies to Buy.

In the report, Citigroup writes "We see three key positives driving a potentially very bullish set-up out the other side of the correction: 1) EPS/cash flow should prove more resilient (especially surprising for AMKR) and companies should still make a lot of money resulting in a re-valuation based on higher “cross-cycle” EPS (much like 2004 but likely more dramatic), 2) chipmakers are now faced w/more capital-intensive “shrinks” as the next wafer size (450mm) is years away; and 3) key factors driving back-end test buy-rate compression have run their course. While these are positive for the entire sector, front-end orders still have ~40-50% risk during 1H:11 while the battle in the back-end is much easier to fight given how much orders are already down. Additionally, back-end stocks are no more expensive than front-end relative to trading levels the past few years so risk appears much lower."

Citigroup has upgraded Amkor from Sell to Buy and has increased the price target from $6 to $10 and has upgraded Teradyne from Hold to Buy and has increased the price target from $13 to $17.

Amkor Technology and Teradyne, Inc. closed Friday at $6.47 and $11.86, respectively.


Related Articles (AMKR + TER)

View Comments and Join the Discussion!

Posted-In: Amkor Technology Citigroup teradyneAnalyst Color Upgrades Price Target Analyst Ratings

Latest Ratings

FSRMorgan StanleyMaintains40.0
MEDDA DavidsonMaintains302.0
VICRBWS FinancialMaintains120.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at